Postessential thrombocythemia (post-et) myelofibrosis Clinical Trials
Conditions / Postessential thrombocythemia (post-et) myelofibrosis
Delta Trials indexes 1 clinical trial for Postessential thrombocythemia (post-et) myelofibrosis in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 13 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
1
Total Trials
0
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
13
Study Locations
Browse by location (13 total)
- Cleveland, United States 1 trialAll trials in Cleveland, United States
- Phoenix, United States 1 trialAll trials in Phoenix, United States
- New York, United States 1 trialAll trials in New York, United States
- The Bronx, United States 1 trialAll trials in The Bronx, United States
- Toronto, Canada 1 trialAll trials in Toronto, Canada
- Durham, United States 1 trialAll trials in Durham, United States
- Jacksonville, United States 1 trialAll trials in Jacksonville, United States
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States
- Baltimore, United States 1 trialAll trials in Baltimore, United States
- Ann Arbor, United States 1 trialAll trials in Ann Arbor, United States
- Houston, United States 1 trialAll trials in Houston, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- St. Louis, United States 1 trialAll trials in St. Louis, United States
- Orange, United States 1 trialAll trials in Orange, United States